Phase 2
Showing 1 - 25 of >10,000
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
- Oral repotrectinib (TPX-0005)
-
Yuma, Arizona
- +175 more
Jan 25, 2023
Type 2 Diabetes Trial in Beijing, Shijiazhuang (HEC88473, Placebo, Dulaglutide)
Recruiting
- Type 2 Diabetes
- HEC88473, Placebo, Dulaglutide
-
Beijing, Beijing, China
- +1 more
Nov 20, 2023
Aging Well Trial in Ann Arbor (Nurse-led health coaching)
Not yet recruiting
- Aging Well
- Nurse-led health coaching
-
Ann Arbor, MichiganUniversity of Michigan School of Nursing
Jun 16, 2023
Rheumatoid Arthritis Trial in Nashville (2-HOBA, Placebo)
Recruiting
- Rheumatoid Arthritis
- 2-HOBA
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 26, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp Trial (HY209GEL Active, Placebo)
Not yet recruiting
- Atopic Dermatitis
- +2 more
- HY209GEL Active
- Placebo
- (no location specified)
Aug 31, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023
Healthy Participants Trial (mPnC candidate, mPnC control)
Not yet recruiting
- Healthy Participants
- mPnC candidate
- mPnC control
- (no location specified)
Oct 30, 2023
Diabetic Peripheral Neuropathic Pain Trial (RTA 901, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- RTA 901
- Placebo
- (no location specified)
May 31, 2023
Dementia Alzheimers Trial in City Of Manila (Virtual reality)
Recruiting
- Dementia Alzheimers
- Virtual reality
-
City Of Manila, National Capital Region, PhilippinesUniversity of the Philippines College of Allied Medical Professi
Oct 5, 2023
Prostate Cancer Trial ([99mTc]Tc-PSMA-T4)
Not yet recruiting
- Prostate Cancer
- [99mTc]Tc-PSMA-T4
- (no location specified)
Apr 26, 2023
Atopic Dermatitis Trial (SAR444656 (KT-474), Placebo)
Not yet recruiting
- Atopic Dermatitis
- SAR444656 (KT-474)
- Placebo
- (no location specified)
Sep 21, 2023
Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)
Not yet recruiting
- Cholangiocarcinoma Non-resectable
- Cholangiocarcinoma Metastatic
- (no location specified)
Oct 10, 2023
Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553 full dose
- +2 more
- (no location specified)
Oct 24, 2023
Hidradenitis Suppurativa Trial (SAR444656 (KT-474), Placebo)
Not yet recruiting
- Hidradenitis Suppurativa
- SAR444656 (KT-474)
- Placebo
- (no location specified)
Aug 31, 2023
Phenylketonuria Trial in Ankara (SAR444836)
Recruiting
- Phenylketonuria
-
Ankara, TurkeyInvestigational Site Number: 7920001
Aug 7, 2023
Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)
Recruiting
- Unresectable Hepatocellular Carcinoma
- Oligometastatic Disease
- SBRT plus tislelizumab and regorafenib
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jun 15, 2023
Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))
Recruiting
- Duchenne Muscular Dystrophy
- Phase 1, SQY51
- +3 more
-
Garches, FranceHôpital Raymond Poincaré
Mar 7, 2023